miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4
Highlights of this study • MiR-187-3p is significantly down-regulated in HCC, and is correlated with adverse clinical features and poor prognosis of HCC patients. • MiR-187-3p can inhibit the metastasis of HCC cells by regulating EMT phenotype. • S100A4 is a direct downstream target of miR-187-3p, a...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2016-10, Vol.381 (2), p.380-390 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights of this study • MiR-187-3p is significantly down-regulated in HCC, and is correlated with adverse clinical features and poor prognosis of HCC patients. • MiR-187-3p can inhibit the metastasis of HCC cells by regulating EMT phenotype. • S100A4 is a direct downstream target of miR-187-3p, and mediated the biological function of miR-187-3p in HCC. • MiR-187-3p can be down-regulated by hypoxia, and is involved in the promoting effects of hypoxia on the metastasis and EMT of HCC cells |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/j.canlet.2016.08.011 |